L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico
The study focuses on the microbiological and economic aspects of the treatment of hospital infections. The following topics are presented and discussed: I) principal microbiological features of infections acquired during hospital stays; II) data on the use of fluoroquinolones in hospital patients; I...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2001-12-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/733 |
id |
doaj-77fd2471c85b46f495852b933eed2b7e |
---|---|
record_format |
Article |
spelling |
doaj-77fd2471c85b46f495852b933eed2b7e2020-11-25T01:53:28ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2001-12-012420121610.7175/fe.v2i4.733680L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomicoMario Eandi0Carlo Della Pepa1Dipartimento di Farmacologia Clinica, Università degli Studi di Torino
Dipartimento di Farmacologia Clinica, Università degli Studi di Torino
The study focuses on the microbiological and economic aspects of the treatment of hospital infections. The following topics are presented and discussed: I) principal microbiological features of infections acquired during hospital stays; II) data on the use of fluoroquinolones in hospital patients; III) cost-analysis of hospital infection treatment; IV) impact of different antibiotics on the selection of resistant strains of Pseudomonas aeruginosa; V) review of pharmacoeconomic data of different antibacterial regimens.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/733 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mario Eandi Carlo Della Pepa |
spellingShingle |
Mario Eandi Carlo Della Pepa L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico Farmeconomia: Health Economics and Therapeutic Pathways |
author_facet |
Mario Eandi Carlo Della Pepa |
author_sort |
Mario Eandi |
title |
L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
title_short |
L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
title_full |
L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
title_fullStr |
L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
title_full_unstemmed |
L’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
title_sort |
l’uso ospedaliero di ciprofloxacina nella terapia parenterale ed orale delle infezioni gravi: profilo farmacoeconomico |
publisher |
SEEd Medical Publishers |
series |
Farmeconomia: Health Economics and Therapeutic Pathways |
issn |
2240-256X |
publishDate |
2001-12-01 |
description |
The study focuses on the microbiological and economic aspects of the treatment of hospital infections. The following topics are presented and discussed: I) principal microbiological features of infections acquired during hospital stays; II) data on the use of fluoroquinolones in hospital patients; III) cost-analysis of hospital infection treatment; IV) impact of different antibiotics on the selection of resistant strains of Pseudomonas aeruginosa; V) review of pharmacoeconomic data of different antibacterial regimens. |
url |
https://journals.seedmedicalpublishers.com/index.php/FE/article/view/733 |
work_keys_str_mv |
AT marioeandi lusoospedalierodiciprofloxacinanellaterapiaparenteraleedoraledelleinfezionigraviprofilofarmacoeconomico AT carlodellapepa lusoospedalierodiciprofloxacinanellaterapiaparenteraleedoraledelleinfezionigraviprofilofarmacoeconomico |
_version_ |
1724990828691062784 |